Ameren Corporation
http://www.ameren.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Ameren Corporation
Multinationals Look To M&A As Key China Growth Driver
Mergers and acquisitions have been highlighted as key drivers of growth for pharma companies in China as domestic companies look to expand globally and multinationals attempt to localize.
Start-Up Quarterly Statistics, Q2 2014
Start-ups raised $893.9 million in Q2 2014, a 25% drop from last quarter’s record-setting $1.18 billion. Metabolic disease was the most prevalent therapeutic category involved in alliances; seven acquisitions were signed, five in the biopharma sector.
Deals Shaping The Medical Industry, June 2014
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced April through May 2014.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice